• Explore /
  • Poster
  • / Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.

Abstract Poster

Authors

null

Mark Charles Korpics

University of Chicago, Chicago, IL

Mark Charles Korpics , Benjamin Ernst Onderdonk , Rebekah E Dadey , Jared H Hara , Lilit Karapetyan , Yuanyuan Zha , Theodore Karrison , Adam C. Olson , Gini F. Fleming , Ralph R. Weichselbaum , Riyue Bao , Steven J. Chmura , Jason J. Luke

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

PD1/PD-L1 Inhibitor Monotherapy

Clinical Trial Registration Number

NCT02608385

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2593)

DOI

10.1200/JCO.2023.41.16_suppl.2593

Abstract #

2593

Poster Bd #

435

Abstract Disclosures

Similar Posters

Poster

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Long-term clinical outcomes and transcriptional analysis following partial and complete tumor SBRT plus pembrolizumab.

Long-term clinical outcomes and transcriptional analysis following partial and complete tumor SBRT plus pembrolizumab.

First Author: Sandeep Ramesh Bhave

First Author: Jeffrey Lemons

First Author: Colette Shen

First Author: David Shao Peng Tan